Whereas some cancers express high levels of αvβ3 (e.g., melanoma and glioblastoma), the discovery that αvβ3 negatively regulates the endothelial cell growth factor receptor VEGFR2 means that blockade of αvβ3 will result in increased angiogenesis and tumour growth (see above). Here, KDR is linked to melanoma.